Stem cell therapy research for Type 1 diabetes receives funding

Greg Korbutt (left) and Andrew Pepper are members of a research team aiming to develop insulin-producing stem cells that won’t trigger an immune response, so transplant patients wouldn't need to take anti-rejection drugs. (Photo: Faculty of Medicine & Dentistry, May 2019)

Reading Time: 5 minutes Three U of A researchers will help lead projects to advance treatments for patients

Pin It on Pinterest